Archemix Names Bate CEO

Xconomy Boston — 

Archemix, a Cambridge, MA-based biotech startup developing aptamer drugs, reports that Kenneth Bate will replace Duncan Higgons as CEO of the company. Higgons, who had become chief executive of the firm in January, is taking a job with another private biotech firm, according to Archemix. Bate was most recently president and CEO of Lexington, MA-based drug developer NitroMed, which walked away from a proposed merger with Archemix early this year.